TY - JOUR
T1 - Treatment of internal carotid aneurysms using pipeline embolization devices
T2 - Measuring the radiation dose of the patient and determining the factors affecting it
AU - Kawauchi, Satoru
AU - Chida, Koichi
AU - Moritake, Takashi
AU - Hamada, Yusuke
AU - Matsumaru, Yuji
AU - Tsuruta, Wataro
AU - Sato, Masayuki
AU - Hosoo, Hisayuki
AU - Sun, Lue
N1 - Funding Information:
This work was partially supported by a Grant-in-Aid for Scientific Research [No. 19K17183] from the Japan Society for the Promotion of Science.
Publisher Copyright:
© 2020 The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
PY - 2020/6/24
Y1 - 2020/6/24
N2 - The purpose of this study was to measure the peak skin dose (PSD) and bilateral lens doses using radiophotoluminescence glass dosimeters and to determine the factors influencing the radiation dose in cases of cerebral aneurysm treated with pipeline embolization devices (PEDs). The cumulative dose, PSD and right and left lens doses were 3818.1 ± 1604.6, 1880.0 ± 723.0, 124.8 ± 49.2 and 180.7 ± 124.8 mGy, respectively. Using multivariate analysis, body mass index (p < 0.01; odds ratio (OR) = 1.806; 95% confidence interval (CI) = 1.007-3.238) and deployment time of PED (p < 0.05; OR = 1.107; 95% CI = 1.001-1.224) were found to be the independent predictors of PSD exceeding 2 Gy. Measures such as collimation of the radiation field and optimization of radiation dose should be taken to reduce the radiation to the patient.
AB - The purpose of this study was to measure the peak skin dose (PSD) and bilateral lens doses using radiophotoluminescence glass dosimeters and to determine the factors influencing the radiation dose in cases of cerebral aneurysm treated with pipeline embolization devices (PEDs). The cumulative dose, PSD and right and left lens doses were 3818.1 ± 1604.6, 1880.0 ± 723.0, 124.8 ± 49.2 and 180.7 ± 124.8 mGy, respectively. Using multivariate analysis, body mass index (p < 0.01; odds ratio (OR) = 1.806; 95% confidence interval (CI) = 1.007-3.238) and deployment time of PED (p < 0.05; OR = 1.107; 95% CI = 1.001-1.224) were found to be the independent predictors of PSD exceeding 2 Gy. Measures such as collimation of the radiation field and optimization of radiation dose should be taken to reduce the radiation to the patient.
UR - http://www.scopus.com/inward/record.url?scp=85087094822&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087094822&partnerID=8YFLogxK
U2 - 10.1093/rpd/ncz298
DO - 10.1093/rpd/ncz298
M3 - Article
C2 - 31922569
AN - SCOPUS:85087094822
SN - 0144-8420
VL - 188
SP - 389
EP - 396
JO - Radiation Protection Dosimetry
JF - Radiation Protection Dosimetry
IS - 3
ER -
